NCF1-339基因多态性与SLE患者中性粒细胞胞外诱捕网形成、干扰素活性及抗磷脂综合征的关联
本研究探讨NCF1-339(rs201802880)低ROS基因型对SLE患者NET形成、I型干扰素活性及抗体谱的影响,并在瑞典四个中心1087例SLE患者中验证。结果发现低ROS基因型患者NET形成受损、依赖线粒体ROS,高血清干扰素活性频率增加(80% vs 21.4%),且抗磷脂抗体及抗磷脂综合征(APS)风险升高(APS OR 1.74,95%CI 1.19-2.55)。
要点
- NCF1-339低ROS基因型SLE患者NET形成受损且更依赖线粒体ROS。
- 低ROS基因型患者高血清干扰素活性频率显著增高(80% vs 21.4%)。
- 低ROS基因型与抗磷脂抗体及APS风险升高相关,APS OR 1.74(95%CI 1.19-2.55)。
核心结论
- NCF1-339介导的NADPH氧化酶功能降低与SLE中高干扰素活性和NET形成受损相关,并意外揭示与磷脂抗体及APS的显著关联。
研究设计与样本
- 对隆德SLE患者分别检测NET释放通路(n=31)、血清干扰素(n=141)和抗体谱(n=305),并按NCF1-339基因型分组。
- 在瑞典四个风湿科中心1087例SLE患者中对NCF1-339基因型进行临床特征验证。
主要发现
- 低ROS基因型SLE患者中性粒细胞NET形成受损(p<0.01)且对线粒体ROS依赖性增加(p<0.05)。
- 低ROS患者高血清干扰素活性频率为80%,而正常ROS基因型为21.4%(p<0.05)。
- 低ROS患者抗β2糖蛋白I抗体(p<0.01)和抗心磷脂抗体(p<0.05)阳性率增加,与其他抗体无关。
- 在全部四个队列(n=1087)中验证任何抗磷脂抗体OR 1.40(95%CI 1.01-1.95)、抗β2糖蛋白I抗体OR 1.82(95%CI 1.02-3.24)及APS OR 1.74(95%CI 1.19-2.55)的过表达。
关键数值与推荐
- 低ROS基因型患者高血清干扰素活性频率80% vs 21.4%(p<0.05)。
- 任何抗磷脂抗体OR 1.40(95%CI 1.01-1.95)。
- 抗β2糖蛋白I抗体OR 1.82(95%CI 1.02-3.24)。
- APS OR 1.74(95%CI 1.19-2.55)。
临床怎么用
- 对SLE患者检测NCF1-339基因型可能有助于识别高干扰素活性、NET形成受损及APS风险升高的亚群。
- 低ROS基因型SLE患者应关注抗磷脂抗体筛查及APS的监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: A single nucleotide polymorphism in the NCF1 gene (NCF1-339, rs201802880), encoding NADPH oxidase type II subunit NCF1/p47phox, reducing production of reactive oxygen species (ROS) is strongly associated with the development of systemic lupus erythematosus (SLE). This study aimed at characterising NCF1-339 effects on neutrophil extracellular trap (NET) formation, type I interferon activity and antibody profile in patients with SLE. METHODS: Neutrophil NET-release pathways (n=31), serum interferon (n=141) and finally antibody profiles (n=305) were investigated in SLE subjects from Lund, genotyped for NCF1-339. Then, 1087 SLE subjects from the rheumatology departments of four Swedish SLE centres, genotyped for NCF1-339, were clinically characterised to validate these findings. RESULTS: Compared with patients with normal-ROS NCF1-339 genotypes, neutrophils from patients with SLE with low-ROS NCF1-339 genotypes displayed impaired NET formation (p<0.01) and increased dependence on mitochondrial ROS (p<0.05). Low-ROS patients also had increased frequency of high serum interferon activity (80% vs 21.4%, p<0.05) and positivity for anti-β2 glycoprotein I (p<0.01) and anticardiolipin antibodies (p<0.05) but were not associated with other antibodies. We confirmed an over-representation of having any antiphospholipid antibody, OR 1.40 (95% CI 1.01 to 1.95), anti-β2 glycoprotein I, OR 1.82 (95% CI 1.02 to 3.24) and the antiphospholipid syndrome (APS), OR 1.74 (95% CI 1.19 to 2.55) in all four cohorts (n=1087). CONCLUSIONS: The NCF1-339 SNP mediated decreased NADPH oxidase function, is associated with high interferon activity and impaired formation of NETs in SLE, allowing dependence on mitochondrial ROS. Unexpectedly, we revealed a striking connection between the ROS deficient NCF1-339 genotypes and the presence of phospholipid antibodies and APS.
引用
- Linge P, Arve S, Olsson LM, et al. NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus. Ann Rheum Dis. 2019. PMID: 31704719. doi:10.1136/annrheumdis-2019-215820
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。